Penetrance for copy number variants associated with schizophrenia

Evangelos Vassos, David A. Collier, Simon Holden, Christine Patch, Dan Rujescu, David M. St Clair, Cathryn M. Lewis

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

The discovery of 'high-risk' de novo copy number variants (CNVs) associated with neuropsychiatric disorders such as schizophrenia offers the opportunity to translate these findings into useful tools for clinical geneticists. However, this will require estimation of penetrance for these variants, which has not yet been properly considered. To facilitate this process, we estimated the penetrance of CNVs associated with schizophrenia, at 15q13.3, 1q21.1, 15q11.2, 17p12, 2p16.3, 16p13.1 and 16p11.2 with a novel Bayesian method applied to pooled data from published case-control studies. For these CNVs, penetrance for schizophrenia was between 2 and 7.4%, which contrasts with the much higher penetrance for schizophrenia of the 22q11.2 deletions found in velo-cardio-facial syndrome. The highest penetrance was for 15q13.3 deletion (6-9% in individual studies) and the lowest was for 15q11.2 (2%). CNVs confer much higher risk for schizophrenia than common variants, but their penetrance is substantially lower than Mendelian disorders or other syndromic conditions. Since these CNVs predispose to multiple disorders, including epilepsy, autism and intellectual impairment, penetrance estimates will also need to take into account diagnostic specificity, and their overall penetrance for any neuropsychiatric disorder is likely to be much higher. Thus, although CNVs are still far from being clinically useful or relevant to genetic counselling for specific disorders, their detection may hold an important clinical value in predicting negative developmental outcomes.
Original languageEnglish
Pages (from-to)3477-3481
Number of pages5
JournalHuman Molecular Genetics
Volume19
Issue number17
Early online date29 Jun 2010
DOIs
Publication statusPublished - 1 Sep 2010

Fingerprint

Penetrance
Schizophrenia
DiGeorge Syndrome
Bayes Theorem
Genetic Counseling
Autistic Disorder
Case-Control Studies
Epilepsy

Keywords

  • case-control studies
  • chromosome deletion
  • DNA copy number variations
  • gene dosage
  • humans
  • schizophrenia

Cite this

Vassos, E., Collier, D. A., Holden, S., Patch, C., Rujescu, D., St Clair, D. M., & Lewis, C. M. (2010). Penetrance for copy number variants associated with schizophrenia. Human Molecular Genetics, 19(17), 3477-3481. https://doi.org/10.1093/hmg/ddq259

Penetrance for copy number variants associated with schizophrenia. / Vassos, Evangelos; Collier, David A.; Holden, Simon; Patch, Christine; Rujescu, Dan; St Clair, David M.; Lewis, Cathryn M.

In: Human Molecular Genetics, Vol. 19, No. 17, 01.09.2010, p. 3477-3481.

Research output: Contribution to journalArticle

Vassos, E, Collier, DA, Holden, S, Patch, C, Rujescu, D, St Clair, DM & Lewis, CM 2010, 'Penetrance for copy number variants associated with schizophrenia', Human Molecular Genetics, vol. 19, no. 17, pp. 3477-3481. https://doi.org/10.1093/hmg/ddq259
Vassos E, Collier DA, Holden S, Patch C, Rujescu D, St Clair DM et al. Penetrance for copy number variants associated with schizophrenia. Human Molecular Genetics. 2010 Sep 1;19(17):3477-3481. https://doi.org/10.1093/hmg/ddq259
Vassos, Evangelos ; Collier, David A. ; Holden, Simon ; Patch, Christine ; Rujescu, Dan ; St Clair, David M. ; Lewis, Cathryn M. / Penetrance for copy number variants associated with schizophrenia. In: Human Molecular Genetics. 2010 ; Vol. 19, No. 17. pp. 3477-3481.
@article{a73b19bbd2bb475384a978b91f459c14,
title = "Penetrance for copy number variants associated with schizophrenia",
abstract = "The discovery of 'high-risk' de novo copy number variants (CNVs) associated with neuropsychiatric disorders such as schizophrenia offers the opportunity to translate these findings into useful tools for clinical geneticists. However, this will require estimation of penetrance for these variants, which has not yet been properly considered. To facilitate this process, we estimated the penetrance of CNVs associated with schizophrenia, at 15q13.3, 1q21.1, 15q11.2, 17p12, 2p16.3, 16p13.1 and 16p11.2 with a novel Bayesian method applied to pooled data from published case-control studies. For these CNVs, penetrance for schizophrenia was between 2 and 7.4{\%}, which contrasts with the much higher penetrance for schizophrenia of the 22q11.2 deletions found in velo-cardio-facial syndrome. The highest penetrance was for 15q13.3 deletion (6-9{\%} in individual studies) and the lowest was for 15q11.2 (2{\%}). CNVs confer much higher risk for schizophrenia than common variants, but their penetrance is substantially lower than Mendelian disorders or other syndromic conditions. Since these CNVs predispose to multiple disorders, including epilepsy, autism and intellectual impairment, penetrance estimates will also need to take into account diagnostic specificity, and their overall penetrance for any neuropsychiatric disorder is likely to be much higher. Thus, although CNVs are still far from being clinically useful or relevant to genetic counselling for specific disorders, their detection may hold an important clinical value in predicting negative developmental outcomes.",
keywords = "case-control studies, chromosome deletion, DNA copy number variations, gene dosage, humans, schizophrenia",
author = "Evangelos Vassos and Collier, {David A.} and Simon Holden and Christine Patch and Dan Rujescu and {St Clair}, {David M.} and Lewis, {Cathryn M.}",
year = "2010",
month = "9",
day = "1",
doi = "10.1093/hmg/ddq259",
language = "English",
volume = "19",
pages = "3477--3481",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "17",

}

TY - JOUR

T1 - Penetrance for copy number variants associated with schizophrenia

AU - Vassos, Evangelos

AU - Collier, David A.

AU - Holden, Simon

AU - Patch, Christine

AU - Rujescu, Dan

AU - St Clair, David M.

AU - Lewis, Cathryn M.

PY - 2010/9/1

Y1 - 2010/9/1

N2 - The discovery of 'high-risk' de novo copy number variants (CNVs) associated with neuropsychiatric disorders such as schizophrenia offers the opportunity to translate these findings into useful tools for clinical geneticists. However, this will require estimation of penetrance for these variants, which has not yet been properly considered. To facilitate this process, we estimated the penetrance of CNVs associated with schizophrenia, at 15q13.3, 1q21.1, 15q11.2, 17p12, 2p16.3, 16p13.1 and 16p11.2 with a novel Bayesian method applied to pooled data from published case-control studies. For these CNVs, penetrance for schizophrenia was between 2 and 7.4%, which contrasts with the much higher penetrance for schizophrenia of the 22q11.2 deletions found in velo-cardio-facial syndrome. The highest penetrance was for 15q13.3 deletion (6-9% in individual studies) and the lowest was for 15q11.2 (2%). CNVs confer much higher risk for schizophrenia than common variants, but their penetrance is substantially lower than Mendelian disorders or other syndromic conditions. Since these CNVs predispose to multiple disorders, including epilepsy, autism and intellectual impairment, penetrance estimates will also need to take into account diagnostic specificity, and their overall penetrance for any neuropsychiatric disorder is likely to be much higher. Thus, although CNVs are still far from being clinically useful or relevant to genetic counselling for specific disorders, their detection may hold an important clinical value in predicting negative developmental outcomes.

AB - The discovery of 'high-risk' de novo copy number variants (CNVs) associated with neuropsychiatric disorders such as schizophrenia offers the opportunity to translate these findings into useful tools for clinical geneticists. However, this will require estimation of penetrance for these variants, which has not yet been properly considered. To facilitate this process, we estimated the penetrance of CNVs associated with schizophrenia, at 15q13.3, 1q21.1, 15q11.2, 17p12, 2p16.3, 16p13.1 and 16p11.2 with a novel Bayesian method applied to pooled data from published case-control studies. For these CNVs, penetrance for schizophrenia was between 2 and 7.4%, which contrasts with the much higher penetrance for schizophrenia of the 22q11.2 deletions found in velo-cardio-facial syndrome. The highest penetrance was for 15q13.3 deletion (6-9% in individual studies) and the lowest was for 15q11.2 (2%). CNVs confer much higher risk for schizophrenia than common variants, but their penetrance is substantially lower than Mendelian disorders or other syndromic conditions. Since these CNVs predispose to multiple disorders, including epilepsy, autism and intellectual impairment, penetrance estimates will also need to take into account diagnostic specificity, and their overall penetrance for any neuropsychiatric disorder is likely to be much higher. Thus, although CNVs are still far from being clinically useful or relevant to genetic counselling for specific disorders, their detection may hold an important clinical value in predicting negative developmental outcomes.

KW - case-control studies

KW - chromosome deletion

KW - DNA copy number variations

KW - gene dosage

KW - humans

KW - schizophrenia

U2 - 10.1093/hmg/ddq259

DO - 10.1093/hmg/ddq259

M3 - Article

VL - 19

SP - 3477

EP - 3481

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 17

ER -